Single nucleotide polymorphisms in the mitochondrial displacement loop region and outcome of malignant fibrous histiocytoma

References

• Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, et al. (1981). Sequence and organization of the human mitochondrial genome. Nature 290:457–65
   PubMed Web of Science ®Google Scholar
• Al-Agha OM, Igbokwe AA. (2008). Malignant fibrous histiocytoma: Between the past and the present. Arch Pathol Lab Med 132:1030–5
   PubMed Web of Science ®Google Scholar
• Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG. (2001). Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J 20:1910–20
   PubMed Web of Science ®Google Scholar
• Bandy B, Davision AJ. (1990). Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8:523–39
   PubMed Web of Science ®Google Scholar
• Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. (2007). Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67:4687–94
   PubMed Web of Science ®Google Scholar
• Cui H, Huang P, Wang Z, Zhang Y, Zhang Z, Xu W, Wang X, et al. (2013). Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer 13:110
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Mambo E, Sidransky D. (2006). Mitochondrial DNA mutations in human cancer. Oncogene 25:4663–74
   PubMed Web of Science ®Google Scholar
• Clayton DA. (1991). Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol 7:453–78
   PubMedGoogle Scholar
• Ding C, Li R, Wang P, Jin P, Li S, Guo Z. (2012). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondrial DNA 23:251–4
   PubMed Web of Science ®Google Scholar
• Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, et al. (2000). Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017–19
   PubMed Web of Science ®Google Scholar
• Gille JJ, Joenje H. (1992). Cell culture models for oxidative stress: Superoxide and hydrogen peroxidative versus normobaric heperoxia. Mutat Res 275:405–14
   PubMed Web of Science ®Google Scholar
• Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, et al. (2001b). Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94:429–31
   PubMed Web of Science ®Google Scholar
• Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, et al. (2001a). Mitochondrial DNA alteration in esophageal cancer. Int J Cancer 92:319–21
   PubMed Web of Science ®Google Scholar
• Hoki Y, Hiraku Y, Ma N, Murata M, Matsumine A, Nagahama M, Shintani K, et al. (2007). iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis. Cancer Sci 98:163–8
   PubMed Web of Science ®Google Scholar
• Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, Oliveira J, et al. (2001). Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20:5195–8
   PubMed Web of Science ®Google Scholar
• Kulawiec M, Arnouk H, Desouki MM, Kazim L, Still I, Singh KK. (2006). Proteomic analysis of proteins involved in mitochondria-to-nucleus retrograde response in human cancer cells. Cancer Biol Ther 8:967–75
   Web of Science ®Google Scholar
• Kim MS, Cho WH, Song WS. (2007). Prognostic significance of Ezrin expression in pleomorphic malignant fibrous histiocytoma. Anticancer Res 27:1171–8
   PubMed Web of Science ®Google Scholar
• Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, et al. (2001). High frequency of mitochondrial DNA mutations in glioblastoma multiformme identified by direct sequence comparison to blood samples. Int J Cancer 93:534–8
   PubMed Web of Science ®Google Scholar
• Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, Roignot P, Arnould L, et al. (2005). Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23:3517–25
   PubMed Web of Science ®Google Scholar
• Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, Wong LC, et al. (2001). High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61:5998–6001
   PubMed Web of Science ®Google Scholar
• Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. (2004). Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547:71–8
   PubMed Web of Science ®Google Scholar
• Maximo V, Soares P, Machado JC, Seruca R, Sobrinho-Simoes M. (2000). Mitochondrial DNA alteration in gastric cancer. Gastroenterology 119:1808–9
   PubMed Web of Science ®Google Scholar
• Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. (2002). Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 8:481–7
   PubMed Web of Science ®Google Scholar
• Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, et al. (2006). Mitochondrial DNA D-loop in pancreatic cancer: Somatic mutations are epiphenomena while the germline 16,519T variant worsens metabolism and outcome. Am J Clin Pathol 126:593–601
   PubMed Web of Science ®Google Scholar
• Ozzello L, Stout AP, Murray MR. (1963). Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16:331–44
   PubMed Web of Science ®Google Scholar
• O’Brien JE, Stout AP. (1964). Malignant fibrous xanthomas. Cancer 17:1445–55
   PubMed Web of Science ®Google Scholar
• Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, et al. (1998). Somatic mutations of the mitochondrial genome in human colorectal tumors. Nat Genet 20:291–3
   PubMed Web of Science ®Google Scholar
• Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, et al. (2001). Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61:7623–6
   PubMed Web of Science ®Google Scholar
• Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO. (2000). Nuclear and mitochondrial instability in human breast cancer. Cancer Res 60:4231–7
   PubMed Web of Science ®Google Scholar
• Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, et al. (2001). Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015–19
   PubMed Web of Science ®Google Scholar
• Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui S. (2005). Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140–6
   PubMed Web of Science ®Google Scholar
• Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM, et al. (2007). Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16:1455–9
   PubMed Web of Science ®Google Scholar
• Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, et al. (2008). Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomark Prev 17:3558–66
   PubMed Web of Science ®Google Scholar
• Wanebo HJ, Koness RJ, MacFarlane JK, Eilber FR, Byers RM, Elias EG, Spiro KH. (1992). Head and neck sarcoma: Report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 14:1–7
   PubMed Web of Science ®Google Scholar
• Weiss SW, Goldbum JR. (2002). Enzinger and Weiss’s soft tissue tumors. 4th ed. St. Louis: Mosby
   Google Scholar
• Weiss MD, Sharon W, Enzinger FM. (1978). Malignant fibrous histiocytoma: An analysis of 200 cases. Cancer 41:2250–66
   PubMed Web of Science ®Google Scholar
• Warburg O. (1956). On the origin of cancer cells. Science 123:309–14
   PubMed Web of Science ®Google Scholar
• Xun J, Li Z, Song X, Wang X. (2013). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as risk biomarkers for malignant fibrous histiocytoma. Mitochondrial DNA [Online]. Available at: http://www.informahealthcare.com/doi/abs/10.3109/19401736.2013.836510 (Accessed on 1 October 2013).
   Google Scholar
• Xie H, Lev D, Gong Y, Wang S, Pollock RK, Wu X, Gu J, et al. (2013). Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis 34:1039–43
   PubMed Web of Science ®Google Scholar
• Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, et al. (2008). Mitochondrial DNA content: Its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst 100:1104–12
   PubMedGoogle Scholar
• Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, et al. (2006). Correlation between copy number of mitochondrial DNA and clinicopathologic parameters of hepatocellular carcinoma. Eur J Surg Oncol 32:303–7
   PubMed Web of Science ®Google Scholar
• Ye C, Shu X, Pierce L, Wen W, Courtney R. (2010). Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat 119:431–6
   PubMed Web of Science ®Google Scholar
• Yeh JJ, Lunetta KL, van Orsouw NJ, Moore Jr FD, Mutter GL, Vijg J, Dahia PL, et al. (2000). Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumors. Oncogene 19:2060–6
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang R, Zhang F, Wu CH, Fan H, Li Y, Guo Z, et al. (2010). Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. Cancer Res 29:155
   Web of Science ®Google Scholar